The Gross Margin of Harbin Medisan Pharmaceutical Co Ltd (002900.SZ) is 32.67%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-12-31 | 32.67% |
| 2024-12-31 | 51.09% |
| 2023-12-31 | 59.93% |
| 2022-12-31 | 64.96% |
| 2021-12-31 | 66.92% |
| 2020-12-31 | 63.60% |
| 2019-12-31 | 75.59% |
| 2018-12-31 | 83.67% |
| 2017-12-31 | 74.05% |
| 2016-12-31 | 61.66% |